fbpx

Teva BP Meds Added to Recall for Cancer Risk

UPDATE – More blood pressure medications added to what is NOW a global recall for potential cancer risk:

[11/29/2018]

Teva Pharmaceuticals has launched a voluntary recall into two drugs used to treat high blood pressure as yet more medications face concerns over a possible cancer risk.

In a statement from Teva posted by the Food and Drug Administration, the recall affects all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug featuring amlodipine, valsartan, and hydrochlorothiazide.

The drugs could contain an impurity called N-nitroso-diethylamine (NDMA), which has been classified as a possible human carcinogen, the FDA said.

Patients taking either drugs should contact their doctor or pharmacist for advice or alternative treatments. Stopping the drugs immediately with no comparable alternative could pose a greater risk to patients’ health, said Teva.

Customers and patients with questions can contact Teva by phone at 888-838-2872, or email at druginfo@tevapharm.com.

Not all Valsartan products contained NDMA, the agency says; the FDA has a list of drugs with NDMA and those not affected on its website.

FDA.GOV WEBSITE RECALL UPDATES
By |2018-11-30T15:44:33+00:00November 30th, 2018|Local News, Medical Recalls, Recalls|0 Comments